3D Systems Corp
DDD2.200USD
+0.210+10.55%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
282.14MMarket Cap
16.86P/E TTM
More Details of 3D Systems Corp Company
3D Systems Corporation provides comprehensive three-dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The Company’s segments include Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment serves industry verticals, including dental, medical devices, personalized health services and regenerative medicine. The Industrial Solutions segment serves industry verticals, including aerospace, defense, transportation and general manufacturing. The Company architects solutions specific to customers’ needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania.
3D Systems Corp Info
Ticker SymbolDDD
Company name3D Systems Corp
IPO dateMar 26, 2011
CEOGraves (Jeffrey A)
Number of employees1833
Security typeOrdinary Share
Fiscal year-endMar 26
Address333 Three D Systems Cir
CityROCK HILL
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code29730
Phone18033263900
Websitehttps://www.3dsystems.com/
Ticker SymbolDDD
IPO dateMar 26, 2011
CEOGraves (Jeffrey A)
Company Executives of 3D Systems Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Charles W. Hull
Dr. Charles W. Hull
Executive Vice President, Chief Technology Officer - Regenerative Medicine
Executive Vice President, Chief Technology Officer - Regenerative Medicine
593.05K
-4929.00%
Mr. Reji Puthenveetil
Mr. Reji Puthenveetil
Executive Vice President - Additive Solutions, Chief Commercial Officer
Executive Vice President - Additive Solutions, Chief Commercial Officer
431.53K
-16050.00%
Mr. Kevin S. Moore
Mr. Kevin S. Moore
Independent Director
Independent Director
271.70K
+29069.00%
Dr. John J. Tracy
Dr. John J. Tracy
Independent Director
Independent Director
180.71K
+29069.00%
Dr. Vasant Padmanabhan
Dr. Vasant Padmanabhan
Independent Director
Independent Director
147.18K
+29069.00%
Mr. Jimmy D. (Jim) Kever, J.D.
Mr. Jimmy D. (Jim) Kever, J.D.
Independent Director
Independent Director
--
--
Mr. Thomas W. Erickson
Mr. Thomas W. Erickson
Independent Director
Independent Director
--
--
Mr. Charles G. (Chip) Mcclure, Jr.
Mr. Charles G. (Chip) Mcclure, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Malissia R. Clinton
Ms. Malissia R. Clinton
Independent Director
Independent Director
--
--
Dr. Jeffrey A. (Jeff) Graves, Ph.D.
Dr. Jeffrey A. (Jeff) Graves, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Charles W. Hull
Dr. Charles W. Hull
Executive Vice President, Chief Technology Officer - Regenerative Medicine
Executive Vice President, Chief Technology Officer - Regenerative Medicine
593.05K
-4929.00%
Mr. Reji Puthenveetil
Mr. Reji Puthenveetil
Executive Vice President - Additive Solutions, Chief Commercial Officer
Executive Vice President - Additive Solutions, Chief Commercial Officer
431.53K
-16050.00%
Mr. Kevin S. Moore
Mr. Kevin S. Moore
Independent Director
Independent Director
271.70K
+29069.00%
Dr. John J. Tracy
Dr. John J. Tracy
Independent Director
Independent Director
180.71K
+29069.00%
Dr. Vasant Padmanabhan
Dr. Vasant Padmanabhan
Independent Director
Independent Director
147.18K
+29069.00%
Mr. Jimmy D. (Jim) Kever, J.D.
Mr. Jimmy D. (Jim) Kever, J.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Products
52.31M
57.33%
Services
38.94M
42.67%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Products
52.31M
57.33%
Services
38.94M
42.67%
Shareholding Stats
Updated: Sat, Jan 31
Updated: Sat, Jan 31
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
State Street Investment Management (US)
6.71%
BlackRock Institutional Trust Company, N.A.
6.14%
Bank of Nova Scotia
5.19%
The Vanguard Group, Inc.
4.97%
Capital World Investors
3.57%
Other
73.43%
Shareholders
Shareholders
Proportion
State Street Investment Management (US)
6.71%
BlackRock Institutional Trust Company, N.A.
6.14%
Bank of Nova Scotia
5.19%
The Vanguard Group, Inc.
4.97%
Capital World Investors
3.57%
Other
73.43%
Shareholder Types
Shareholders
Proportion
Investment Advisor
24.29%
Investment Advisor/Hedge Fund
14.56%
Hedge Fund
8.70%
Research Firm
6.67%
Bank and Trust
5.36%
Individual Investor
3.77%
Family Office
0.97%
Venture Capital
0.27%
Sovereign Wealth Fund
0.09%
Other
35.30%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
525
86.77M
65.34%
-385.78K
2025Q3
554
87.16M
66.88%
+21.71M
2025Q2
554
65.46M
65.17%
-1.74M
2025Q1
566
67.79M
64.38%
-19.36M
2024Q4
570
74.57M
59.91%
+2.30M
2024Q3
566
72.36M
70.47%
-13.78M
2024Q2
562
86.29M
71.34%
-546.64K
2024Q1
569
86.87M
74.59%
-12.80M
2023Q4
580
87.85M
72.95%
+717.28K
2023Q3
585
87.01M
77.26%
-4.04M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
State Street Investment Management (US)
9.80M
6.71%
-81.32K
-0.82%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.97M
6.14%
-261.43K
-2.83%
Sep 30, 2025
Bank of Nova Scotia
8.18M
5.6%
+8.18M
--
Sep 30, 2025
The Vanguard Group, Inc.
7.32M
5.01%
-84.73K
-1.14%
Sep 30, 2025
Capital World Investors
5.21M
3.57%
+5.21M
--
Sep 30, 2025
Two Sigma Investments, LP
4.24M
2.9%
+2.12M
+99.80%
Sep 30, 2025
D. E. Shaw & Co., L.P.
3.19M
2.18%
+2.48M
+353.22%
Sep 30, 2025
Geode Capital Management, L.L.C.
3.16M
2.16%
-8.47K
-0.27%
Sep 30, 2025
Morgan Stanley & Co. LLC
3.02M
2.07%
+1.14M
+60.80%
Sep 30, 2025
ICON Advisers, Inc.
2.60M
1.78%
+500.00K
+23.81%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Pacer BlueStar Engineering the Future ETF
9.74%
ProShares S&P Kensho Smart Factories ETF
6.3%
3D Printing ETF
3.91%
State Street SPDR S&P Kensho New Econ Comp ETF
0.76%
Gabelli Automation ETF
0.63%
iShares Micro-Cap ETF
0.07%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
iShares Russell 2000 Value ETF
0.02%
Global X Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
View more
Pacer BlueStar Engineering the Future ETF
Proportion9.74%
ProShares S&P Kensho Smart Factories ETF
Proportion6.3%
3D Printing ETF
Proportion3.91%
State Street SPDR S&P Kensho New Econ Comp ETF
Proportion0.76%
Gabelli Automation ETF
Proportion0.63%
iShares Micro-Cap ETF
Proportion0.07%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.03%
iShares Russell 2000 Value ETF
Proportion0.02%
Global X Russell 2000 ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
